On May 6th, GLOBAL and DS-Connect hosted two important webinars in English and Spanish with over 150 attendees!

In the pivotal webinar (in English and Spanish) co-hosted by the Global Down Syndrome Foundation and DS-Connect, Dr. Joaquín Espinosa, Executive Director of the Linda Crnic Institute for Down Syndrome, dove into the newly enhanced DS-Connect®: The Down Syndrome Registry. This upgraded platform aims to empower individuals with Down syndrome and their families to contribute valuable health information, thereby accelerating research and improving health outcomes. Dr. Espinosa emphasized that participation is voluntary and confidential, providing a secure environment for sharing health data. He also highlighted the importance of this registry in connecting participants with research opportunities and clinical studies. This webinar underscored how collective contributions can lead to a deeper understanding of Down syndrome and inform better healthcare practices.  He gave a demonstration on just how user friendly the system is.  To learn more and sign up, please, click here.

English Presentation: Click Here

Video de la Presentación: Haga click aquí 

Joaquín Espinosa, PhD, is the Executive Director for Science at the Linda Crnic Institute for Down Syndrome. He is also a Professor in the Department of Pharmacology at the University of Colorado Denver School of Medicine and the founding Director of the Functional Genomics Facility at the University of Colorado. Under Dr. Espinosa’s leadership and in collaboration with the Global Down Syndrome Foundation, the Crnic Institute’s Human Trisome Project was launched and has become one of the largest cohort studies of people with Down syndrome to date. In addition, his team is leading clinical trials testing immunomodulatory therapies for autoimmune conditions, Down syndrome Regression Disorder, and improved early neurodevelopment. He also serves as the Leader of the Administrative and Outreach Core of the INCLUDE Data Coordinating Center, an NIH-funded resource aiming to accelerate discoveries by facilitating access to and analysis of large scale datasets form cohort studies of the population with Down syndrome.